BMY.RT
T. Rowe Price Associates’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,063,106
| Closed | -$4.18M | – | 2900 |
|
|
2020
Q4 | $4.18M | Buy |
6,063,106
+1,764,386
| +41% | +$1.22M | ﹤0.01% | 1466 |
|
|
2020
Q3 | $9.67M | Buy |
4,298,720
+591,511
| +16% | +$1.33M | ﹤0.01% | 1308 |
|
|
2020
Q2 | $13.3M | Sell |
3,707,209
-92,536
| -2% | -$331K | ﹤0.01% | 1240 |
|
|
2020
Q1 | $14.4M | Sell |
3,799,745
-201,100
| -5% | -$764K | ﹤0.01% | 1159 |
|
|
2019
Q4 | $12M | Buy |
+4,000,845
| New | +$12M | ﹤0.01% | 1282 |
|